ATXI | Avenue Therapeutics, Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	14.54 Million	8.04 Million	3.73 Million	5.21 Million	26.26 Million	21.81 Million
Selling, General and Administrative Expenses	4.17 Million	5.34 Million	2.48 Million	2.34 Million	3.07 Million	4.12 Million
Research and Development Expenses	10.36 Million	2.69 Million	1.25 Million	2.86 Million	23.19 Million	17.69 Million
Other Expenses	-	-	-	-	-	175 Thousand
Cost and Expenses	14.54 Million	8.04 Million	3.73 Million	5.21 Million	26.26 Million	21.81 Million
Operating Income	-14.54 Million	-8.04 Million	-3.73 Million	-5.21 Million	-26.26 Million	-21.81 Million
Interest Expense	-	1.16 Million	-	-	-	-
Income Tax Expense	-	-5.65 Million	-7000.00	-62 Thousand	-357 Thousand	-268 Thousand
Earnings before Tax	-10.48 Million	-3.6 Million	-3.73 Million	-5.15 Million	-25.9 Million	-21.54 Million
Net Income	-10.37 Million	2.04 Million	-3.72 Million	-5.08 Million	-25.55 Million	-21.28 Million
Earnings Per Share Basic	-73.60	0.94	-3.29	-4.62	-24.38	-31.17
Earnings Per Share Diluted	-73.48	0.94	-3.29	-4.62	-24.38	-31.17
Weighted Average Shares Outstanding	141 Thousand	2.18 Million	1.13 Million	1.1 Million	1.04 Million	682.61 Thousand
Weighted Average Shares Outstanding (Diluted)	141.22 Thousand	2.18 Million	1.13 Million	1.1 Million	1.04 Million	682.61 Thousand
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	4.05 Million	-	-	-5.21 Million	-	-
Earnings Before Tax Margin	-	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	2.82 Million	3.7 Million	14.54 Million	2.11 Million	2.06 Million	3.92 Million
Selling, General and Administrative Expenses	1.46 Million	1.31 Million	-	1.13 Million	1.16 Million	896 Thousand
Research and Development Expenses	1.36 Million	2.39 Million	-	982 Thousand	907 Thousand	3.02 Million
Other Expenses	-1.46 Million	-574 Thousand	-	-	-	-
Cost and Expenses	2.82 Million	3.7 Million	14.54 Million	2.11 Million	2.06 Million	3.92 Million
Operating Income	-2.82 Million	-3.7 Million	-14.54 Million	-2.11 Million	-2.06 Million	-3.92 Million
Interest Expense	-	-	-	-332 Thousand	-	-
Income Tax Expense	4.48 Million	9000.00	-111 Thousand	-23 Thousand	-2068.00	-66 Thousand
Earnings before Tax	-2.7 Million	-4.34 Million	-10.48 Million	617 Thousand	526 Thousand	-4.01 Million
Net Income	-7.18 Million	-4.34 Million	-10.37 Million	640 Thousand	526 Thousand	-4 Million
Earnings Per Share Basic	-6.43	-7.72	-	0.02	0.06	-0.52
Earnings Per Share Diluted	-6.43	-7.72	-	0.02	0.06	-0.52
Weighted Average Shares Outstanding	1.11 Million	562.04 Thousand	141.22 Thousand	25.59 Million	8.11 Million	7.75 Million
Weighted Average Shares Outstanding (Diluted)	1.11 Million	562.04 Thousand	141.22 Thousand	25.59 Million	8.11 Million	7.75 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-2.82 Million	-3.7 Million	-	-2.11 Million	-2.06 Million	-3.86 Million
Earnings Before Tax Margin	-	-	-	-	-	-